Hyaluronate and Derivatives and Minims Cyclopentolate 1%
Determining the interaction of Hyaluronate and Derivatives and Minims Cyclopentolate 1% and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: hyaluronan
Brand name: Hymovis, Monovisc, Orthovisc, Hydase
Synonyms: Hyaluronan
Generic Name: cyclopentolate ophthalmic
Brand name: Cyclogyl, Cylate, AK-Pentolate, Pentolair, Ocu-Pentolate
Synonyms: Cyclopentolate ophthalmic, Cyclopentolate Hydrochloride
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Hyaluronate and Derivatives-Minims Pilocarpine 2%
- Hyaluronate and Derivatives-Minims Pilocarpine 4%
- Hyaluronate and Derivatives-Minims prednisoLONE 0.5%
- Hyaluronate and Derivatives-Minipress
- Hyaluronate and Derivatives-Miniprin
- Hyaluronate and Derivatives-Minirin
- Minims Cyclopentolate 1%-Hyaluronate and Derivatives Injection (Knee)
- Minims Cyclopentolate 1%-Hyaluronate sodium Injection
- Minims Cyclopentolate 1%-Hyaluronidase
- Minims Cyclopentolate 1%-Hyaluronidase and immune globulin
- Minims Cyclopentolate 1%-Hyaluronidase and rituximab
- Minims Cyclopentolate 1%-Hyaluronidase and trastuzumab